* WISKY: AI-Powered Retinal Disease Diagnostic Solution WISKY is an advanced solution that performs real-time analysis of images captured by fundus cameras to detect age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma. It serves as a vital tool for internal medicine clinics, f...
Manufactured by
South Korea
ARK INC. is a company dedicated to improving the quality of life for all people by developing early disease detection solutions based on artificial intelligence (AI). As a subsidiary of Pusan National University Hospital, ARK leverages trustworthy national university hospital data and a standardized clinical research system to develop highly accurate AI diagnostic algorithms. ⸻ Flagship Product – WISKY: AI-based Ophthalmic Disease Screening Solution WISKY, the flagship product of ARK, is an AI-powered retinal disease screening platform. Using a single fundus image, WISKY can simultaneously detect three major causes of blindness in real time: • Diabetic Retinopathy • Age-related Macular Degeneration (AMD) • Glaucoma Recognized for its diagnostic accuracy and ease of use, WISKY has been designated as an Innovative Medical Device in Korea. This technology is highly regarded for its market potential, especially amid the rising incidence of retinal diseases due to an aging population and chronic conditions. ⸻ Advanced AI Technology Powered by Big Data • ARK has built a comprehensive dataset of over 500,000 retinal images, which serves as the foundation for a robust and optimized AI training model. • The diagnostic system is user-friendly, allowing even non-specialist medical staff to operate it easily. • This makes it particularly suitable for primary care settings, such as community health centers and local clinics. With this technological advantage, ARK is actively expanding into global markets as well as strengthening its domestic presence.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Optain Health
Australia · 2 relevant products
Remidio Innovative Solutions Pvt. Ltd.
India · 5 relevant products
Hangzhou Deepwise & League of PHD Technology Co.,Ltd.
China · 4 relevant products
Verge HealthTech Fund
Singapore · 2 relevant products
CHECK-EYE
Germany · 1 relevant product
Mediwhale Inc.
South Korea · 3 relevant products
Feipu Intelligent Technology (Shanghai) Co., Ltd.
China · 2 relevant products
cas-ruiyi
China · 1 relevant product
Eyeonic Ltd Pty
Australia · 1 relevant product
iAMBITION TECHNOLOGY CO., LTD.
Taiwan · 2 relevant products
31 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 56 closest product alternatives
Optain Health · Australia
AI-enabled Software as a Medical Device (SaMD) that analyzes full-colour retinal images to screen for referable eye diseases and cardiovascular disease risk. The software generates instant risk assessment reports for clinical decision-making and patient care optimization.
Remidio Innovative Solutions Pvt. Ltd. · India
AI-powered screening system for diabetic retinopathy detection using fundus imaging. Enables non-invasive, population-scale vision screening in primary care and community settings to identify patients requiring specialist referral. Combines portable fundus photography with machine learning algorithms for early disease detection and risk stratification.
Optain Health · Australia
An AI-enabled clinical support tool that analyzes full-color retinal images to screen for referable eye diseases and evaluate patient health. The non-invasive solution uses advanced algorithms to provide accurate assessments and standardized care recommendations for providers, patients, and insurers.
Hangzhou Deepwise & League of PHD Technology Co.,Ltd. · China
AI-powered diagnostic system designed to assist clinicians in stroke detection and assessment using medical imaging analysis. Leverages deep learning algorithms to process imaging data and provide rapid diagnostic support for acute stroke cases. Integrates with existing healthcare IT infrastructure to enhance clinical workflow efficiency and diagnostic accuracy.
Remidio Innovative Solutions Pvt. Ltd. · India
An AI and telemedicine platform specifically designed for diabetic retinopathy screening and monitoring. This system uses automated algorithms to detect and analyze diabetic retinopathy from retinal images.
Verge HealthTech Fund · Singapore
AI-enabled clinical decision support software for early detection, monitoring, and treatment of age-related macular degeneration.
CHECK-EYE · Germany
Software system utilizing artificial intelligence algorithms to analyze retinal imaging data. Processes fundus photographs to identify pathological changes and generates clinical reports. Integrates with pharmacy and health center networks for distributed screening programs.
Remidio Innovative Solutions Pvt. Ltd. · India
An AI and telemedicine platform for age-related macular degeneration screening and monitoring. This system uses automated algorithms to detect and analyze age-related macular degeneration from retinal images.
Verge HealthTech Fund · Singapore
AI-enabled software platform for early detection, monitoring, and treatment management of age-related macular degeneration. The system assists clinicians in identifying and managing AMD progression through intelligent clinical decision support.
Mediwhale Inc. · South Korea
Feipu Intelligent Technology (Shanghai) Co., Ltd. · China
AI-powered non-invasive health screening system that integrates multimodal optical imaging with computational biology models to assess multiple health parameters including glucose, blood pressure, and body composition from facial analysis. Combines digital biomarkers with machine learning algorithms for real-time multi-dimensional health predictions across clinical and consumer health settings.
cas-ruiyi · China
EyeKnow is an AI-powered eye-tracking system for cognitive and neurological assessment. It records and analyzes eye movement trajectories to evaluate brain health, cognitive function, and neurodegenerative conditions. The platform integrates advanced eye-tracking hardware with artificial intelligence for screening, diagnosis, and monitoring of neurological disorders across clinical settings.
44 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products